| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $0 | — | — |
| R&D Expense | $22.9M | -16.9% | -37.7% |
| SG&A Expense | $10.8M | +27.7% | -26.2% |
| Operating Income | -$33.7M | +6.4% | +34.4% |
| Pre-tax Income | -$26.7M | +0.7% | +33.6% |
| Income Tax | $0 | — | +100.0% |
| Net Income | -$26.7M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $39.1M | +3.9% | -5.4% |
| Accounts Receivable | $0 | — | — |
| Current Assets | $288.3M | -7.5% | -28.0% |
| Total Assets | $327.3M | -7.0% | -27.4% |
| Current Liabilities | $37.2M | -4.8% | -32.3% |
| Total Liabilities | $74.4M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$94.3M | — | — |
| Capital Expenditures | $0 | — | — |
| Investing Cash Flow | $99.2M | — | — |
| Financing Cash Flow | $304K | — | — |
| Free Cash Flow | -$94.3M | — | — |
| +33.5% |
| EPS (Basic) | -$0.37 | +0.0% | +33.9% |
| EPS (Diluted) | -$0.37 | +0.0% | +33.9% |
| -3.7% |
| -22.8% |
| Stockholders' Equity | $252.9M | -7.9% | -28.6% |